Phillip Yates

Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial

Man‐Fung Yuen, Jeong Heo, Jeong-Won Jang et al. · Nature Medicine · 2021 · 153 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

CT scanning of middle ear cholesteatoma: what does the surgeon want to know?

Phillip Yates, L M Flood, Anirban Banerjee et al. · British Journal of Radiology · 2002 · 56 citations

Medicine, Otolaryngology, Surgery +14

Experimental Infection of Ponies with Equine Influenza A2 (H3N8) Virus Strains of Different Pathogenicity Elicits Varying Interferon and Interleukin-6 Responses

Eva Wattrang, D.M. Jessett, Phillip Yates et al. · Viral Immunology · 2003 · 45 citations

Agriculture, Immunology, Infectious Diseases +14

In Vitro Antiviral Activity of the Novel, Tyrosyl-Based Human Immunodeficiency Virus (HIV) Type 1 Protease Inhibitor Brecanavir (GW640385) in Combination with Other Antiretrovirals and against a Panel of Protease Inhibitor-Resistant HIV

Richard Hazen, Robert G. Ferris, Charles Craig et al. · Antimicrobial Agents and Chemotherapy · 2007 · 36 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Efficacy and Safety of Danirixin (GSK1325756) Co-administered With Standard-of-Care Antiviral (Oseltamivir): A Phase 2b, Global, Randomized Study of Adults Hospitalized With Influenza

Anuradha Madan, Shuguang Chen, Phillip Yates et al. · Open Forum Infectious Diseases · 2019 · 29 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17